HLA Health HourMedicaid & MedicareInsuranceMental HealthNutritionFind a ProviderHealth JobsProvider Corner
Healthcare Markets
UNH 339.90 ▼0.05%ELV 394.35 ▼0.26%CI 269.35 ▼0.80%CVS 80.94 ▲0.08%HUM 390.00 ▼0.03%CNC 64.00 ▲0.33%MOH 198.50 ▲0.00%HCA 473.00 ▼0.64%THC 263.19 ▲0.00%UHS 179.43 ▼0.12%LLY 1349.30 ▲0.04%PFE 27.39 ▼0.15%JNJ 270.64 ▼0.01%MRK 133.05 ▼0.55%ABBV 286.99 ▼0.18%NVO 37.92 ▲0.29%MDT 100.30 ▲0.23%ABT 102.75 ▼0.54%ISRG 400.04 ▲0.25%XLV 177.40 ▲0.03%Delayed quotes. Not investment advice.UNH 339.90 ▼0.05%ELV 394.35 ▼0.26%CI 269.35 ▼0.80%CVS 80.94 ▲0.08%HUM 390.00 ▼0.03%CNC 64.00 ▲0.33%MOH 198.50 ▲0.00%HCA 473.00 ▼0.64%THC 263.19 ▲0.00%UHS 179.43 ▼0.12%LLY 1349.30 ▲0.04%PFE 27.39 ▼0.15%JNJ 270.64 ▼0.01%MRK 133.05 ▼0.55%ABBV 286.99 ▼0.18%NVO 37.92 ▲0.29%MDT 100.30 ▲0.23%ABT 102.75 ▼0.54%ISRG 400.04 ▲0.25%XLV 177.40 ▲0.03%Delayed quotes. Not investment advice.
Friday, November 20, 2026
Edition
HELPMORNING BRIEFING
HLA Network News
HealthLink of America
HEALTHLINK OF AMERICA NEWS / RESOURCES
NORTH CAROLINA HEALTH PLANS
NC MedicaidMedicareBlue Cross NCHealthy BlueAmeriHealth Caritas NCCarolina Complete HealthUnitedHealthcare Community PlanWellCare of NCAlliance HealthTrillium Health ResourcesVaya PartnersAetnaHumanaCigna
All plans ›
ADVERTISEMENT
ADVERTISE WITH HLA NETWORK NEWS
Reach patients, families and providers in their city.
Health brands only. Banner, sidebar, section, directory, jobs and Morning Briefing placements.
GET THE MEDIA KIT
World Health · national

New malaria vaccine shows 87% efficacy in early human trial

A genetically modified vaccine prevented infection in most vaccinated participants exposed to malaria in a phase 1 study.

A new malaria vaccine called PfSPZ-LARC2 prevented infection in 87% of vaccinated people in an early-stage human trial, Medical Xpress reported. Researchers at UW Medicine and partners exposed vaccinated and unvaccinated participants to malaria 12 to 16 weeks after vaccination. All seven people who received a placebo became infected, while only two of 15 vaccinated people developed the disease.

The vaccine uses a genetically modified version of the malaria parasite. All infected participants were safely treated, and the vaccine was well tolerated by those who received it, according to the report.

Researchers presented these findings at the annual meeting of the American Society of Tropical Medicine and Hygiene. The trial, which began enrolling participants in summer 2025, was led by Dr. Sean Murphy at the University of Washington School of Medicine and involved researchers from Fred Hutch Cancer Center and UW School of Medicine.

Malaria kills more than 600,000 people worldwide each year, according to Medical Xpress. Vaccines that completely prevent infection are needed, rather than just reducing symptom severity, researchers said.

What it means in Raleigh

RALEIGH HEALTH SYSTEM
State agency: NC Department of Health and Human Services (NCDHHS)
Behavioral health: Alliance Health (LME/MCO for Wake, Durham, Johnston, Orange, Cumberland, Mecklenburg)
Medicaid plans: NC Medicaid Standard Plans: AmeriHealth Caritas NC, Carolina Complete Health, Healthy Blue, UnitedHealthcare Community Plan, WellCare of NC. Tailored Plans: Alliance Health, Trillium Health Resources, Vaya Partners (Vaya Health + Partners Health Management, merged 2026).
Major insurers: Blue Cross NC, Aetna, Cigna, UnitedHealthcare, Humana
Plan lists change; confirm with your plan or the state agency.

Sources

Not medical advice. HLA Network News reports health news. Talk to your doctor or care team about your own care. In a crisis, call or text 988. In an emergency, call 911.
ADVERTISEMENT · SIDEBAR 300x250
Reach health readers here. Advertise with HLA